DuckWiseDuckWise Get the app

Archive › XBIT

XBIT trade ideas: every closed DuckWise idea on XBiotech Inc.

DuckWise has published 1 idea on XBiotech Inc. (XBIT, Stock) that has closed between July 2020 and September 2020. Each is listed below with the levels published before the position was taken and its result at close — 1 in profit, 0 at a loss.

1closed idea
1 / 0in profit / at a loss
+23.61%average result
55 daystypical holding period
OpenedClosedSideEntryStopProjectionCloseResultDays
Jul 22, 2020Sep 15, 2020Long16.05—2019.84+23.61%55

Prices in US dollars. Prices are as traded on the day. Result is the price change from the published entry to the published close plus dividends received while the idea was held (paid, for shorts), before fees, taxes and slippage. How results are counted.

XBIT questions and answers

Has DuckWise published trade ideas on XBIT?

Yes. DuckWise has published 1 idea on XBiotech Inc. (XBIT) that closed between July 2020 and September 2020: 1 closed in profit and 0 at a loss. The average result was +23.61% from the published entry to the published close, dividends included.

What was the latest closed DuckWise idea on XBIT?

A long idea opened on July 22, 2020 with an entry of $16.05 and a price projection of $20.00. It closed on September 15, 2020 at $19.84, a result of +23.61% after 55 days.

How long did DuckWise hold its XBIT ideas?

The typical XBIT idea was held about 55 days from entry to close. DuckWise ideas are swing and position trades, not day trades.

Is there an open DuckWise idea on XBIT right now?

Not at the moment. When DuckWise publishes a new idea on XBIT, app subscribers get a push notification; it appears on this page once it closes.

Is this page a stock forecast for XBIT or a recommendation to buy it?

No. This page records closed ideas only. Each price projection was a published level for a model idea, not a forecast of where XBIT will trade. The research is general and impersonal, not a recommendation to buy or sell XBIT or any other security.

More trade ideas on the record

Every ticker in the archive · Track record by year

About XBiotech Inc.

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. Does not pay dividends.

These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell XBIT or any other security.